-
1
-
-
0035035768
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
-
Pauwels RA, Buist AS, Calverley PM, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 1256-1276
-
-
Pauwels, R.A.1
Buist, A.S.2
Calverley, P.M.3
-
2
-
-
0031020213
-
Prehospitalization inhaled corticosteroid use in patients with COPD or asthma
-
Jackevicius C, Joyce DP, Kesten S, et al.: Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997, 111:296-302.
-
(1997)
Chest
, vol.111
, pp. 296-302
-
-
Jackevicius, C.1
Joyce, D.P.2
Kesten, S.3
-
3
-
-
0032992798
-
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice
-
EOLO Group
-
Miravitlles M, Mayordomo C, Arles M, et al.: Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Respir Med 1999, 93:173-179.
-
(1999)
Respir Med
, vol.93
, pp. 173-179
-
-
Miravitlles, M.1
Mayordomo, C.2
Arles, M.3
-
4
-
-
0033033896
-
Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995
-
Van Andel AE, Reisner C, Menjoge SS, et al.: Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 1999, 115:703-707.
-
(1999)
Chest
, vol.115
, pp. 703-707
-
-
Van Andel, A.E.1
Reisner, C.2
Menjoge, S.S.3
-
5
-
-
0034988161
-
Cellular and structural bases of chronic obstructive pulmonary disease
-
Saetta M, Turato G, Maestrelli P, et al.: Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1304-1309.
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 1304-1309
-
-
Saetta, M.1
Turato, G.2
Maestrelli, P.3
-
6
-
-
0037320195
-
Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease
-
Fabbri LM, Romagnoli M, Corbetta L, et al.: Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:418-424.
-
(2003)
Am J Respir Crit Care Med
, vol.167
, pp. 418-424
-
-
Fabbri, L.M.1
Romagnoli, M.2
Corbetta, L.3
-
7
-
-
0032696013
-
Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease
-
Culpitt SV, Nightingale JA, Barnes PJ: Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1635-1639.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 1635-1639
-
-
Culpitt, S.V.1
Nightingale, J.A.2
Barnes, P.J.3
-
8
-
-
0031045482
-
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
-
Keatings VM, Jatakanon A, Worsdell YM, et al.: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997, 155:542-548.
-
(1997)
Am J Respir Crit Care Med
, vol.155
, pp. 542-548
-
-
Keatings, V.M.1
Jatakanon, A.2
Worsdell, Y.M.3
-
9
-
-
0034942614
-
In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation
-
Loppow D, Schleiss MB, Kanniess F, et al.: In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001, 95:115-121.
-
(2001)
Respir Med
, vol.95
, pp. 115-121
-
-
Loppow, D.1
Schleiss, M.B.2
Kanniess, F.3
-
10
-
-
0029972142
-
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
-
Meagher LC, Cousin JM, Seckl JR, et al.: Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996, 156:4422-4428.
-
(1996)
J Immunol
, vol.156
, pp. 4422-4428
-
-
Meagher, L.C.1
Cousin, J.M.2
Seckl, J.R.3
-
11
-
-
0034012129
-
No effect of inhaled budesonide on the response to inhaled ozone in normal subjects
-
Nightingale JA, Rogers DF, Chung KF, et al.: No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. Am J Respir Crit Care Med 2000, 161:479-486.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 479-486
-
-
Nightingale, J.A.1
Rogers, D.F.2
Chung, K.F.3
-
12
-
-
0036727142
-
Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue
-
Gizycki MJ, Hattotuwa KL, Barnes N, et al.: Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002, 57:799-803. This article reviews the pattern of inflammation found in COPD and the subsequent effects of inhaled fluticasone.
-
(2002)
Thorax
, vol.57
, pp. 799-803
-
-
Gizycki, M.J.1
Hattotuwa, K.L.2
Barnes, N.3
-
13
-
-
0037097883
-
The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease
-
Hattotuwa KL, Gizycki MJ, Ansari TW, et al.: The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165:1592-1596. This article reviews the pattern of inflammation found in COPD and the subsequent effects of inhaled fluticasone.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 1592-1596
-
-
Hattotuwa, K.L.1
Gizycki, M.J.2
Ansari, T.W.3
-
14
-
-
0034727828
-
Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
-
Anonymous: Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000, 343:1902-1909.
-
(2000)
N Engl J Med
, vol.343
, pp. 1902-1909
-
-
-
15
-
-
0029866161
-
Effects of long-term treatment with corticosteroids in CIOD
-
Renkema TE, Schouten JP, Koeter GH, et al.: Effects of long-term treatment with corticosteroids in CIOD. Chest 1996, 109:1156-1162.
-
(1996)
Chest
, vol.109
, pp. 1156-1162
-
-
Renkema, T.E.1
Schouten, J.P.2
Koeter, G.H.3
-
16
-
-
0034643610
-
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
-
Burge PS, Calverley PM, Jones PW, et al.: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320:1297-1303.
-
(2000)
BMJ
, vol.320
, pp. 1297-1303
-
-
Burge, P.S.1
Calverley, P.M.2
Jones, P.W.3
-
17
-
-
33748979747
-
BTS guidelines for the management of chronic obstructive pulmonary disease
-
British Thoracic Society: BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997, 52(suppl 5):S1-28.
-
(1997)
Thorax
, vol.52
, Issue.5 SUPPL.
-
-
-
18
-
-
0042354673
-
Prednisolone response in patients with chronic obstructive pulmonary disease: Results from the ISOLDE study
-
Burge PS, Calverley PMA, Jones PW, et al.: Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003, 58:654-658. This article shows that a trial of corticosteroids does not predict subsequent response to inhaled fluticasone propionate.
-
(2003)
Thorax
, vol.58
, pp. 654-658
-
-
Burge, P.S.1
Calverley, P.M.A.2
Jones, P.W.3
-
19
-
-
0032973833
-
A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease
-
Weir DC, Bale GA, Bright P, et al.: A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease. Clin Exp Allergy 1999, 20(suppl 2):125-128.
-
(1999)
Clin Exp Allergy
, vol.20
, Issue.2 SUPPL.
, pp. 125-128
-
-
Weir, D.C.1
Bale, G.A.2
Bright, P.3
-
20
-
-
0033614639
-
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial
-
Vestbo J, Serensen T, Lange P, et al.: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 1999, 353:1819-1823.
-
(1999)
Lancet
, vol.353
, pp. 1819-1823
-
-
Vestbo, J.1
Serensen, T.2
Lange, P.3
-
21
-
-
0345188819
-
Long-term treatment with inhaled b budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
-
Pauwels RA, Lofdahl CG, Laitinen LA, et al.: Long-term treatment with inhaled b budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999, 340:1948-1953.
-
(1999)
N Engl J Med
, vol.340
, pp. 1948-1953
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Laitinen, L.A.3
-
23
-
-
0032911831
-
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A meta-analysis
-
van Grunsven PM, van Schayck CP, Derenne JP, et al.: Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 1999, 54:7-14.
-
(1999)
Thorax
, vol.54
, pp. 7-14
-
-
Van Grunsven, P.M.1
Van Schayck, C.P.2
Derenne, J.P.3
-
24
-
-
0242577949
-
Contemporary management of chronic obstructive pulmonary disease
-
Sin DD, McAlister FA, Man SFP, et al.: Contemporary management of chronic obstructive pulmonary disease. JAMA 2003, 290:2301-2312. This is an excellent comprehensive meta-analysis that reviews all aspects of management of COPD.
-
(2003)
JAMA
, vol.290
, pp. 2301-2312
-
-
Sin, D.D.1
McAlister, F.A.2
Man, S.F.P.3
-
25
-
-
0037321260
-
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: Dose the dose matter?
-
Sin DD, Man SFD: Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: dose the dose matter? Eur Respir J 2003, 21:260-266. This study uses a population database to evaluate survival and dose-relationship in patients treated with inhaled corticosteroids with COPD.
-
(2003)
Eur Respir J
, vol.21
, pp. 260-266
-
-
Sin, D.D.1
Man, S.F.D.2
-
26
-
-
0035880882
-
Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease
-
Sin DD, Tu JV: Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:580-584.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 580-584
-
-
Sin, D.D.1
Tu, J.V.2
-
27
-
-
0036798266
-
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
-
Soriano JB, Vestbo J, Pride NB, et al.: Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002, 20:810-825. This analysis using a population database looks at survival benefit from combination therapy with fluticasone propionate and salmeterol.
-
(2002)
Eur Respir J
, vol.20
, pp. 810-825
-
-
Soriano, J.B.1
Vestbo, J.2
Pride, N.B.3
-
28
-
-
0041865230
-
Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: Immortal time bias in observational studies
-
Suissa S: Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003, 168:49-50. This study reviews potential biases of epidemiology studies, and shows that with alternative analysis, there is no survival benefit from inhaled corticosteroids.
-
(2003)
Am J Respir Crit Care Med
, vol.168
, pp. 49-50
-
-
Suissa, S.1
-
29
-
-
0036063208
-
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
-
Alsaeedi A, Sin DD, McAlister FA: The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002, 113:59-65. This is an excellent comprehensive systematic review of randomized placebo-controlled trials of inhaled corticosteroids.
-
(2002)
Am J Med
, vol.113
, pp. 59-65
-
-
Alsaeedi, A.1
Sin, D.D.2
McAlister, F.A.3
-
30
-
-
0032515756
-
Multi-center randomised placebo controlled trial of inhaled fluticasone in patients with chronic obstructive pulmonary disease
-
Paggiaro PL, Dagle R, Bakran I, et al.: Multi-center randomised placebo controlled trial of inhaled fluticasone in patients with chronic obstructive pulmonary disease. Lancet 1998, 351:773-780.
-
(1998)
Lancet
, vol.351
, pp. 773-780
-
-
Paggiaro, P.L.1
Dagle, R.2
Bakran, I.3
-
31
-
-
0037246565
-
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
-
On behalf of the ISOLDE study investigators
-
Jones PW, Willits LR, Burge PS, et al.: On behalf of the ISOLDE study investigators. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003, 21:68-73. This is a post-hoc analysis that evaluates the effect of fluticasone propionate based on disease severity.
-
(2003)
Eur Respir J
, vol.21
, pp. 68-73
-
-
Jones, P.W.1
Willits, L.R.2
Burge, P.S.3
-
32
-
-
0033542041
-
Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
-
Lipworth BJ: Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999, 159:941-995.
-
(1999)
Arch Intern Med
, vol.159
, pp. 941-995
-
-
Lipworth, B.J.1
-
33
-
-
0038498561
-
Lack of long-term adverse adrenal effects from inhaled triamcinolone
-
Eichenhorn MS, Wise RA, Madhok TC, et al.: Lack of long-term adverse adrenal effects from inhaled triamcinolone. Chest 2003, 124:57-62. This study evaluates inhaled triamcinolone's effect on adrenal suppression.
-
(2003)
Chest
, vol.124
, pp. 57-62
-
-
Eichenhorn, M.S.1
Wise, R.A.2
Madhok, T.C.3
-
34
-
-
0026754748
-
Risk of osteoporosis in men with chronic bronchitis
-
Pract JP, Peretz A: Risk of osteoporosis in men with chronic bronchitis. Osteoporosis Int 1992, 2:257-261.
-
(1992)
Osteoporosis Int
, vol.2
, pp. 257-261
-
-
Pract, J.P.1
Peretz, A.2
-
36
-
-
0028811651
-
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
-
Hanania NA, Chapman KR, Sturtridge WC, et al.: Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995, 96:571-579.
-
(1995)
J Allergy Clin Immunol
, vol.96
, pp. 571-579
-
-
Hanania, N.A.1
Chapman, K.R.2
Sturtridge, W.C.3
-
37
-
-
0029884478
-
Bone density in asthmatic patients taking inhaled corticosteroids: Comparison of budesonide and beclomethasone dipropionate
-
Packe GE, Robb O, Robins SP, et al.: Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J Roy Coll Phys Lond 1996, 30:128-132.
-
(1996)
J Roy Coll Phys Lond
, vol.30
, pp. 128-132
-
-
Packe, G.E.1
Robb, O.2
Robins, S.P.3
-
38
-
-
0031825521
-
Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids
-
Ebeling PR, Erbas B, Hopper JL, et al.: Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Min Res 1998, 13:1283-1289.
-
(1998)
J Bone Min Res
, vol.13
, pp. 1283-1289
-
-
Ebeling, P.R.1
Erbas, B.2
Hopper, J.L.3
-
39
-
-
0034701480
-
Inhaled corticosteroid use and bone-mineral density in patients with asthma
-
Wong CA, Walsh U, Smith CJP, et al.: Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000, 355:1399-1403.
-
(2000)
Lancet
, vol.355
, pp. 1399-1403
-
-
Wong, C.A.1
Walsh, U.2
Smith, C.J.P.3
-
40
-
-
0031947795
-
Association between corticosteroid use and vertebral fractures in older men with chronic obstructive ease
-
McEvoy CE, Ensrud KE, Bender E, et al.: Association between corticosteroid use and vertebral fractures in older men with chronic obstructive ease. Am J Respir Crit Care Med 1998, 157:704-709.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 704-709
-
-
McEvoy, C.E.1
Ensrud, K.E.2
Bender, E.3
-
41
-
-
0035991327
-
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler ®
-
Johnell O, Pauwels R, Löfdahl C-G, et al.: Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler ®. Eur Respir J 2002, 19:1058-1063. This study evaluates the effect of budesonide on bone mineral density.
-
(2002)
Eur Respir J
, vol.19
, pp. 1058-1063
-
-
Johnell, O.1
Pauwels, R.2
Löfdahl, C.-G.3
-
42
-
-
0037111198
-
Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
-
van der Valk P, Monninkhof E, van der Palen J, et al.: Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2002, 166:1358-1363. This study evaluates the effect of withdrawal of inhaled corticosteroids on respiratory symptoms and exacerbation rates.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 1358-1363
-
-
Van Der Valk, P.1
Monninkhof, E.2
Van Der Palen, J.3
-
43
-
-
0034901163
-
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
-
Korn SH, Jerre A, Brattsand R: Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001, 17:1059-1061.
-
(2001)
Eur Respir J
, vol.17
, pp. 1059-1061
-
-
Korn, S.H.1
Jerre, A.2
Brattsand, R.3
-
44
-
-
0036191465
-
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts
-
Spoelstra FM, Postma DS, Hovenga H, et al.: Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002, 57:237-241.
-
(2002)
Thorax
, vol.57
, pp. 237-241
-
-
Spoelstra, F.M.1
Postma, D.S.2
Hovenga, H.3
-
45
-
-
0036153433
-
Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and oral corticosteroids
-
Barnes P: Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and oral corticosteroids. Eur Respir J 2002, 19:182-191.
-
(2002)
Eur Respir J
, vol.19
, pp. 182-191
-
-
Barnes, P.1
-
46
-
-
0037246566
-
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
-
Szafranski W, Cukier A, Ramierez A, et al.: Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:74-81. This study compares key outcomes of pulmonary function, respiratory symptoms, quality of life, and exacerbation rate in patients on combination therapy with budesonide/formoterol versus monotherapy and placebo.
-
(2003)
Eur Respir J
, vol.21
, pp. 74-81
-
-
Szafranski, W.1
Cukier, A.2
Ramierez, A.3
-
47
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomized controlled trial
-
Calverley P, Pauwels R, Vestbo J, et al.: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003, 361:449-456. This study compares key outcomes of pulmonary function, respiratory symptoms, quality of life, and exacerbation rate in patients on combination therapy with budesonide/formoterol versus monotherapy and placebo.
-
(2003)
Lancet
, vol.361
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
-
48
-
-
0031001720
-
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
-
Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
-
(1997)
Lancet
, vol.349
, pp. 1498-1504
-
-
Murray, C.J.1
Lopez, A.D.2
-
49
-
-
0037336007
-
Costs of chronic bronchitis and COPD
-
Miravitlles M, Murio C, Guerrero T, et al.: Costs of chronic bronchitis and COPD. Chest 2003, 123:784-791.
-
(2003)
Chest
, vol.123
, pp. 784-791
-
-
Miravitlles, M.1
Murio, C.2
Guerrero, T.3
-
51
-
-
0035110276
-
The costs of treating COPD in the United States
-
Strassels SA, Smith DH, Sullivan SD, et al.: The costs of treating COPD in the United States. Chest 2001, 119:344-352.
-
(2001)
Chest
, vol.119
, pp. 344-352
-
-
Strassels, S.A.1
Smith, D.H.2
Sullivan, S.D.3
|